One way private equity differs from other for-profit investments is by aiming to maximize profitability while minimizing long-term holdings in such investments. Valuation for private equity acquisitions in health care has grown to over 150 billion dollars since 2020, and expansion continues. One reason private equity investment in the health sector deserves close ethical attention is that private equity firms are, generally, not interested in managing patient panels, clinician personnel, or making service delivery streams work for patients. Another reason is that influx of private equity investment in health care tends to consolidate markets for health services, undermining competition and driving up costs for patients. This theme issue considers which criteria should be used to determine whether, when, and for whom buying and selling of private equity in health care stands up to ethical, clinical, and legal scrutiny and considers how to better guide and regulate private equity transactions in health care.

Background image by Sara Gironi Carnevale.